Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial
Denkert, C., Loibl, S., Müller, B.M., Eidtmann, H., Schmitt, W.D., Eiermann, W., Gerber, B., Tesch, H., Hilfrich, J., Huober, J., Fehm, T., Barinoff, J., Jackisch, C., Prinzler, J., Rüdiger, T., Erbstößer, E., Blohmer, J.U., Budczies, J., Mehta, K.M., von Minckwitz, G.
Published in Annals of oncology (01.11.2013)
Published in Annals of oncology (01.11.2013)
Get full text
Journal Article
The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use
Eiermann, W., Rezai, M., Kümmel, S., Kühn, T., Warm, M., Friedrichs, K., Schneeweiss, A., Markmann, S., Eggemann, H., Hilfrich, J., Jackisch, C., Witzel, I., Eidtmann, H., Bachinger, A., Hell, S., Blohmer, J.
Published in Annals of oncology (01.03.2013)
Published in Annals of oncology (01.03.2013)
Get full text
Journal Article
Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro)
von Minckwitz, G., Rezai, M., Fasching, P.A., Huober, J., Tesch, H., Bauerfeind, I., Hilfrich, J., Eidtmann, H., Gerber, B., Hanusch, C., Blohmer, J.U., Costa, S.D., Jackisch, C., Paepke, S., Schneeweiss, A., Kümmel, S., Denkert, C., Mehta, K., Loibl, S., Untch, M.
Published in Annals of oncology (01.01.2014)
Published in Annals of oncology (01.01.2014)
Get full text
Journal Article
Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer – The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29)
von Minckwitz, G, Rezai, M, Tesch, H, Huober, J, Gerber, B, Zahm, D.M, Hilfrich, J, Costa, S.D, Dubsky, P, Blohmer, J.U, Denkert, C, Hanusch, C, Jackisch, C, Kümmel, S, Fasching, P.A, Schneeweiss, A, Paepke, S, Untch, M, Burchardi, N, Mehta, K, Loibl, S
Published in European journal of cancer (1990) (01.09.2016)
Published in European journal of cancer (1990) (01.09.2016)
Get full text
Journal Article
Pegfilgrastim ± ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study
von Minckwitz, G., Kümmel, S., du Bois, A., Eiermann, W., Eidtmann, H., Gerber, B., Hilfrich, J., Huober, J., Costa, S. D., Jackisch, C., Grasshoff, S.-T., Vescia, S., Skacel, T., Loibl, S., Mehta, K. M., Kaufmann, M.
Published in Annals of oncology (01.02.2008)
Published in Annals of oncology (01.02.2008)
Get full text
Journal Article
Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial
von Minckwitz, G., Eidtmann, H., Loibl, S., Blohmer, J.-U., Costa, S.-D., Fasching, P.A., Kreienberg, R., Hilfrich, J., Gerber, B., Hanusch, C., Fehm, T., Strumberg, D., Solbach, C., Nekljudova, V., Untch, M.
Published in Annals of oncology (01.02.2011)
Published in Annals of oncology (01.02.2011)
Get full text
Journal Article
In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study
von Minckwitz, G., Blohmer, J.-U., Raab, G., Löhr, A., Gerber, B., Heinrich, G., Eidtmann, H., Kaufmann, M., Hilfrich, J., Jackisch, C., Zuna, I., Costa, S. D.
Published in Annals of oncology (01.01.2005)
Published in Annals of oncology (01.01.2005)
Get full text
Journal Article
RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy
Denkert, C., Loibl, S., Kronenwett, R., Budczies, J., von Törne, C., Nekljudova, V., Darb-Esfahani, S., Solbach, C., Sinn, B.V., Petry, C., Müller, B.M., Hilfrich, J., Altmann, G., Staebler, A., Roth, C., Ataseven, B., Kirchner, T., Dietel, M., Untch, M., von Minckwitz, G.
Published in Annals of oncology (01.03.2013)
Published in Annals of oncology (01.03.2013)
Get full text
Journal Article
Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trial
Blohmer, J.-U., Schmid, P., Hilfrich, J., Friese, K., Kleine-Tebbe, A., Koelbl, H., Sommer, H., Morack, G., Wischnewsky, M.B., Lichtenegger, W., Kuemmel, S.
Published in Annals of oncology (01.07.2010)
Published in Annals of oncology (01.07.2010)
Get full text
Journal Article
Dose-Dense Doxorubicin, Docetaxel, and Granulocyte Colony-Stimulating Factor Support With or Without Tamoxifen as Preoperative Therapy in Patients With Operable Carcinoma of the Breast: A Randomized, Controlled, Open Phase IIb Study
VON MINCKWITZ, Gunter, COSTA, Serban D, EIERMANN, Wolfgang, GRAF, Erika, F, Manfred Kaufmann, RAAB, Günter, BLOHMER, Jens-Uwe, EIDTMANN, Holger, HILFRICH, Jörn, MERKLE, Elisabeth, JACKISCH, Christian, GADEMANN, Günther, TULUSAN, Augustinos H
Published in Journal of clinical oncology (01.08.2001)
Published in Journal of clinical oncology (01.08.2001)
Get full text
Journal Article
Topotecan chemotherapy in patients with breast cancer and brain metastases: results of a pilot study
Oberhoff, C, Kieback, D G, Würstlein, R, Deertz, H, Sehouli, J, van Soest, C, Hilfrich, J, Mesrogli, M, von Minckwitz, G, Staab, H J, Schindler, A E
Published in Onkologie (01.06.2001)
Published in Onkologie (01.06.2001)
Get more information
Journal Article
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
Coleman, R, Powles, T, Paterson, A, Gnant, M, Anderson, S, Diel, I, Gralow, J, von Minckwitz, G, Moebus, V, Bergh, J, Pritchard, KI, Bliss, J, Cameron, D, Evans, V, Pan, H, Peto, R, Bradley, R, Gray, R, Bartsch, R, Dubsky, P, Fesl, C, Fohler, H, Greil, R, Jakesz, R, Lang, A, Luschin-Ebengreuth, G, Marth, C, Mlineritsch, B, Samonigg, H, Singer, CF, Steger, GG, Stoger, H, Olivotto, I, Ragaz, J, Christiansen, P, Ejlertsen, B, Ewertz, M, Jensen, MB, Moller, S, Mouridsen, HT, Eiermann, W, Hilfrich, J, Jonat, W, Kaufmann, M, Kreienberg, R, Schumacher, M, Blohmer, JU, Costa, SD, Eidtmann, H, Gerber, B, Jackisch, C, Loibl, S, Dafni, U, Markopoulos, C, Blomqvist, C, Saarto, T, Ahn, JH, Jung, KH, Perrone, F, Bass, G, Brown, A, Bryant, J, Costantino, J, Dignam, J, Fisher, B, Geyer, C, Mamounas, EP, Paik, S, Redmond, C, Swain, S, Wickerham, L, Wolmark, N, Perez, E, Ingle, JN, Suman, VJ, Hadji, P, A'Hern, R, Dowsett, M, Makris, A, Parton, M, Pennert, K, Powles, TJ, Smith, IE, Yarnold, JR, Clack, G, Van Poznak, C, Safra, T, Bell, R, Coleman, RE, Dodwell, D, Hinsley, S, Marshall, HC, Solomayer, E, Fehm, T, Lester, J, Winter, MC, Horsman, JM, Aft, R, Brufsky, AM, Llombart, HA
Published in The Lancet (British edition) (03.10.2015)
Published in The Lancet (British edition) (03.10.2015)
Get full text
Journal Article
24 Zoledronic acid (ZOL) as add-on therapy in patients with tumour residuals after neoadjuvant chemotherapy for primary breast cancer – first interim safety analysis of the NATAN study (GBG 36)
von Minckwitz, G, Zahm, M.D, Eidtmann, H, Tesch, H, du Bois, A, Schwedler, K, Hilfrich, J, Jackisch, C, Mehta, K, Gerber, B
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial
Jakesz, Raimund, Jonat, Walter, Gnant, Michael, Mittlboeck, Martina, Greil, Richard, Tausch, Christoph, Hilfrich, Joern, Kwasny, Werner, Menzel, Christian, Samonigg, Hellmut, Seifert, Michael, Gademann, Guenther, Kaufmann, Manfred
Published in The Lancet (British edition) (06.08.2005)
Published in The Lancet (British edition) (06.08.2005)
Get full text
Journal Article
Neoadjuvant treatment of HER2 overexpressing primary breast cancer with trastuzumab given concomitantly to epirubicin/ cyclophosphamide followed by docetaxel ± capecitabine. First analysis of efficacy and safety of the GBG/AGO multicenter intergroup-study “GeparQuattro”
Untch, M, Rezai, M, Loibl, S, Fasching, P.A, Huober, J, Tesch, H, Bauerfeind, I, Hilfrich, J, Mehta, K, von Minckwitz, G
Published in European journal of cancer supplements (2008)
Published in European journal of cancer supplements (2008)
Get full text
Journal Article
Capecitabine given concomitantly or in sequence with EC → docetaxel as neoadjuvant treatment for early breast cancer: GeparQuattro – a GBG/AGO intergroup-study
von Minckwitz, G, Rezai, M, Loibl, S, Fasching, P.A, Huober, J, Tesch, H, Bauerfeind, I, Hilfrich, J, Mehta, K, Untch, M
Published in European journal of cancer supplements (2008)
Published in European journal of cancer supplements (2008)
Get full text
Journal Article
The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer
Costa, S D, von Minckwitz, G, Raab, G, Blohmer, J U, Dresel, V, Eidtmann, H, Hilfrich, J, Jackisch, C, Merkle, E, Gademann, G, Kaufmann, M
Published in Seminars in oncology (01.06.1999)
Get more information
Published in Seminars in oncology (01.06.1999)
Journal Article
Neoadjuvant Vinorelbine–Capecitabine Versus Docetaxel–Doxorubicin–Cyclophosphamide in Early Nonresponsive Breast Cancer: Phase III Randomized GeparTrio Trial
von Minckwitz, Gunter, Kümmel, Sherko, Vogel, Petra, Hanusch, Claus, Eidtmann, Holger, Hilfrich, Jörn, Gerber, Bernd, Huober, Jens, Costa, Serban Dan, Jackisch, Christian, Loibl, Sibylle, Mehta, Keyur, Kaufmann, Manfred
Published in JNCI : Journal of the National Cancer Institute (16.04.2008)
Published in JNCI : Journal of the National Cancer Institute (16.04.2008)
Get full text
Journal Article
Intensified Neoadjuvant Chemotherapy in Early-Responding Breast Cancer: Phase III Randomized GeparTrio Study
von Minckwitz, Gunter, Kümmel, Sherko, Vogel, Petra, Hanusch, Claus, Eidtmann, Holger, Hilfrich, Jörn, Gerber, Bernd, Huober, Jens, Costa, Serban Dan, Jackisch, Christian, Loibl, Sibylle, Mehta, Keyur
Published in JNCI : Journal of the National Cancer Institute (16.04.2008)
Published in JNCI : Journal of the National Cancer Institute (16.04.2008)
Get full text
Journal Article